tiprankstipranks
180 Life Sciences (ATNF)
NASDAQ:ATNF
US Market

180 Life Sciences (ATNF) Stock Price & Analysis

212 Followers

ATNF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.86 - $51.30
Previous Close$1.96
Volume199.35K
Average Volume (3M)101.79K
Market Cap
$1.80M
Enterprise Value-$508.01K
Total Cash (Recent Filing)$2.66M
Total Debt (Recent Filing)$355.10K
Price to Earnings (P/E)>-0.1
Beta1.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-64.33
Shares Outstanding852,772
10 Day Avg. Volume125,328
30 Day Avg. Volume101,794
Standard Deviation0.96
R-Squared0.02
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.72
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ATNF FAQ

What was 180 Life Sciences’s price range in the past 12 months?
180 Life Sciences lowest stock price was $1.85 and its highest was $51.30 in the past 12 months.
    What is 180 Life Sciences’s market cap?
    Currently, no data Available
    When is 180 Life Sciences’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were 180 Life Sciences’s earnings last quarter?
    Currently, no data Available
    Is 180 Life Sciences overvalued?
    According to Wall Street analysts 180 Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does 180 Life Sciences pay dividends?
      180 Life Sciences does not currently pay dividends.
      What is 180 Life Sciences’s EPS estimate?
      180 Life Sciences’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does 180 Life Sciences have?
      180 Life Sciences has 852,772 shares outstanding.
        What happened to 180 Life Sciences’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of 180 Life Sciences?
        Currently, no hedge funds are holding shares in ATNF
        ---

        Company Description

        180 Life Sciences

        KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in Newark, DE.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Intellia Therapeutics
        Crispr Therapeutics AG
        Editas Medicine
        Sangamo Biosciences
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis